Benefit of extending the dosing interval of long-acting antipsychotic injections in elderly schizophrenics with cognitive dysfunction

Psychogeriatrics. 2017 Nov;17(6):522-523. doi: 10.1111/psyg.12258. Epub 2017 Mar 20.

Authors

Hidenobu Suzuki¹, Hiroyuki Hibino², Yuichi Inoue³, Ayako Mikami⁴, Hideo Matsumoto⁵, Katsunaka Mikami⁵

Affiliations

¹ Department of Psychiatry, Suzuki Clinic, Tokyo, Japan.
² Department of Psychiatry, Fukui Kinen Hospital, Kanagawa, Japan.
³ Department of Psychiatry, Shakomae Kokorono Clinic, Tokyo, Japan.
⁴ Department of Data Science, Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan.
⁵ Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.

PMID: 28321952
DOI: 10.1111/psyg.12258

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antipsychotic Agents / administration & dosage*
Cognitive Dysfunction / drug therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Risperidone / administration & dosage*
Schizophrenia / drug therapy*
Treatment Outcome

Substances

Antipsychotic Agents
Risperidone